
Grey Wolf Therapeutics
Developer of a drug discovery platform intended to offer oncology therapies that focus on immune oncology. The company offers selective inhibitors, small-molecule therapeutics that change tumour antig...
Valuation
$0
Share Price
N/A
Total Raised
$128.6M
Last Round
N/A